108 related articles for article (PubMed ID: 31917547)
1. Engineering the Orientation, Density, and Flexibility of Single-Domain Antibodies on Nanoparticles To Improve Cell Targeting.
Yong KW; Yuen D; Chen MZ; Johnston APR
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5593-5600. PubMed ID: 31917547
[TBL] [Abstract][Full Text] [Related]
2. Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency.
Yong KW; Yuen D; Chen MZ; Porter CJH; Johnston APR
Nano Lett; 2019 Mar; 19(3):1827-1831. PubMed ID: 30773887
[TBL] [Abstract][Full Text] [Related]
3. Oriented conjugation of single-domain antibodies and quantum dots.
Brazhnik K; Nabiev I; Sukhanova A
Methods Mol Biol; 2014; 1199():129-40. PubMed ID: 25103805
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of oxaliplatin with PEGylated-nanobody for enhancing tumor targeting and prolonging circulation.
Li L; Zhu Y; Liu M; Jin D; Zhang L; Cheng J; Liu Y
J Inorg Biochem; 2021 Oct; 223():111553. PubMed ID: 34340059
[TBL] [Abstract][Full Text] [Related]
5. Optimizing protein coordination to quantum dots with designer peptidyl linkers.
Boeneman Gemmill K; Deschamps JR; Delehanty JB; Susumu K; Stewart MH; Glaven RH; Anderson GP; Goldman ER; Huston AL; Medintz IL
Bioconjug Chem; 2013 Feb; 24(2):269-81. PubMed ID: 23379817
[TBL] [Abstract][Full Text] [Related]
6. Binding of muscimol-conjugated quantum dots to GABAC receptors.
Gussin HA; Tomlinson ID; Little DM; Warnement MR; Qian H; Rosenthal SJ; Pepperberg DR
J Am Chem Soc; 2006 Dec; 128(49):15701-13. PubMed ID: 17147380
[TBL] [Abstract][Full Text] [Related]
7. Single-domain antibodies as promising experimental tools in imaging and isolation of porcine epidemic diarrhea virus.
Yang S; Li L; Yin S; Shang Y; Khan MUZ; He X; Yuan L; Gao X; Liu X; Cai J
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8931-8942. PubMed ID: 30143837
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.
Zarschler K; Prapainop K; Mahon E; Rocks L; Bramini M; Kelly PM; Stephan H; Dawson KA
Nanoscale; 2014 Jun; 6(11):6046-56. PubMed ID: 24777583
[TBL] [Abstract][Full Text] [Related]
9. Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length.
Pereira Gomes C; Leiro V; Ferreira Lopes CD; Spencer AP; Pêgo AP
Acta Biomater; 2018 Sep; 78():247-259. PubMed ID: 30092376
[TBL] [Abstract][Full Text] [Related]
10. Aqueous Synthesis of PEGylated Quantum Dots with Increased Colloidal Stability and Reduced Cytotoxicity.
Ulusoy M; Jonczyk R; Walter JG; Springer S; Lavrentieva A; Stahl F; Green M; Scheper T
Bioconjug Chem; 2016 Feb; 27(2):414-26. PubMed ID: 26567697
[TBL] [Abstract][Full Text] [Related]
11. Improving the targeting of therapeutics with single-domain antibodies.
Turner KB; Alves NJ; Medintz IL; Walper SA
Expert Opin Drug Deliv; 2016; 13(4):561-70. PubMed ID: 26689649
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-functionalized PEG-b-PCL polymersomes and their targeting study.
Zou T; Dembele F; Beugnet A; Sengmanivong L; Trepout S; Marco S; de Marco A; Li MH
J Biotechnol; 2015 Nov; 214():147-55. PubMed ID: 26433047
[TBL] [Abstract][Full Text] [Related]
13. Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody".
Sharifi J; Khirehgesh MR; Akbari B; Soleymani B; Mansouri K
Mol Biotechnol; 2021 Jun; 63(6):525-533. PubMed ID: 33772436
[TBL] [Abstract][Full Text] [Related]
14. Targeting graphene quantum dots to epidermal growth factor receptor for delivery of cisplatin and cellular imaging.
Nasrollahi F; Koh YR; Chen P; Varshosaz J; Khodadadi AA; Lim S
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():247-257. PubMed ID: 30423706
[TBL] [Abstract][Full Text] [Related]
15. Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Ramos-Gomes F; Bode J; Sukhanova A; Bozrova SV; Saccomano M; Mitkovski M; Krueger JE; Wege AK; Stuehmer W; Samokhvalov PS; Baty D; Chames P; Nabiev I; Alves F
Sci Rep; 2018 Mar; 8(1):4595. PubMed ID: 29545609
[TBL] [Abstract][Full Text] [Related]
16. sdAb-DB: The Single Domain Antibody Database.
Wilton EE; Opyr MP; Kailasam S; Kothe RF; Wieden HJ
ACS Synth Biol; 2018 Nov; 7(11):2480-2484. PubMed ID: 30441908
[TBL] [Abstract][Full Text] [Related]
17. Generation of single-domain antibody multimers with three different self-associating peptides.
Wang L; Liu X; Zhu X; Wang L; Wang W; Liu C; Cui H; Sun M; Gao B
Protein Eng Des Sel; 2013 Jun; 26(6):417-23. PubMed ID: 23538432
[TBL] [Abstract][Full Text] [Related]
18. Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
Tintelnot J; Baum N; Schultheiß C; Braig F; Trentmann M; Finter J; Fumey W; Bannas P; Fehse B; Riecken K; Schuetze K; Bokemeyer C; Rösner T; Valerius T; Peipp M; Koch-Nolte F; Binder M
Mol Cancer Ther; 2019 Apr; 18(4):823-833. PubMed ID: 30824613
[TBL] [Abstract][Full Text] [Related]
19. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
[TBL] [Abstract][Full Text] [Related]
20. Polyethyleneimine-polyethylene glycol copolymer targeted by anti-HER2 nanobody for specific delivery of transcriptionally targeted tBid containing construct.
Saqafi B; Rahbarizadeh F
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):501-511. PubMed ID: 30810413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
